News
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into ...
Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...
Rallybio (RLYB) announced that it received an equity milestone payment of $12.5M from Recursion Pharmaceuticals (RXRX). The milestone payment was ...
The most profound failures in history are not those that bet big and lost, but those that failed to bet at all. Incremental advances will never cure Alzheimer’s disease or reverse climate change. To ...
Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.
Venice: After a fourteen-year absence, McElwee returns to filmmaking with an affecting tribute to his son’s life that doubles ...
Recursion, Exscientia, and AI drug discovery’s moment of truth Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.
Central bank buying can continue to hold the floor for gold, but a re-ignition of ETF inflows is needed for prices to break out higher once again.” – Natasha Kaneva, head of global commodities ...
With vibe-coding, anyone can become a coder. But can they grow into a software engineer?
Thanks to AI, we’re entering a new era where software completes tasks independently, taking software far beyond being a tool ...
Bulk Rename Utility is a lightweight, easy-to-use file renamer. Effortlessly rename multiple files or folders with flexible options—minimal memory use means it runs quietly in the background.
Tim Tangherlini recently joined the I School in a joint-appointment with the Department of Scandinavian. His research centers around the circulation of stories on and across social networks, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results